Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig B Langman

Showing results (41-50 of 111) with videos related to

Pageof 12
Sort By:
Kidney International Reports|April 29, 2021
Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary HyperoxaluriaGema Ariceta, Kelly Barrios, Bob D Brown, et al.
Pediatric Transplantation|May 10, 2002
Hepatic osteodystrophy in chronic cholestasis: evidence for a multifactorial etiologyGordon L Klein, Humberto Soriano, Robert J Shulman, et al.
Kidney International Reports|November 20, 2018
Autonomic Nervous System Dysregulation in Monozygous Twins With Nephropathic CystinosisEllen R Brooks, Fang Deng, Debra E Weese-Mayer, et al.
Journal of Endourology|October 24, 2013
Defining variation in urinary oxalate in hyperoxaluric stone formersJodi A Antonelli, Craig B Langman, Christopher Odom, et al.
American Journal of Nephrology|August 17, 2016
A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading EnzymeCraig B Langman, Danica Grujic, Rita M Pease, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|April 16, 2008
Bioelectric impedance predicts total body water, blood pressure, and heart rate during hemodialysis in children and adolescentsEllen R Brooks, Sahar A Fatallah-Shaykh, Craig B Langman, et al.
Age and Ageing|May 13, 2006
Women with wrist fractures are at increased risk for future fractures because of both skeletal and non-skeletal risk factorsBeatrice J Edwards, Craig B Langman, Kathy Martinez, et al.
International Urology and Nephrology|February 21, 2019
ALLN-177, oral enzyme therapy for hyperoxaluriaJames E Lingeman, Gyan Pareek, Linda Easter, et al.
Journal of Pediatric Orthopedics|November 25, 2015
Vitamin D Insufficiency and Fracture Risk in Urban ChildrenRachel M Thompson, Daniel M Dean, Sarah Goldberg, et al.
The Journal of Pediatrics|July 27, 2014
Fibroblast growth factor-23 in obese, normotensive adolescents is associated with adverse cardiac structureFarah N Ali, Bonita Falkner, Samuel S Gidding, et al.
Pageof 12

Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
Kidney International Reports|April 29, 2021
Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary HyperoxaluriaGema Ariceta, Kelly Barrios, Bob D Brown, et al.
Pediatric Transplantation|May 10, 2002
Hepatic osteodystrophy in chronic cholestasis: evidence for a multifactorial etiologyGordon L Klein, Humberto Soriano, Robert J Shulman, et al.
Kidney International Reports|November 20, 2018
Autonomic Nervous System Dysregulation in Monozygous Twins With Nephropathic CystinosisEllen R Brooks, Fang Deng, Debra E Weese-Mayer, et al.
Journal of Endourology|October 24, 2013
Defining variation in urinary oxalate in hyperoxaluric stone formersJodi A Antonelli, Craig B Langman, Christopher Odom, et al.
American Journal of Nephrology|August 17, 2016
A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading EnzymeCraig B Langman, Danica Grujic, Rita M Pease, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|April 16, 2008
Bioelectric impedance predicts total body water, blood pressure, and heart rate during hemodialysis in children and adolescentsEllen R Brooks, Sahar A Fatallah-Shaykh, Craig B Langman, et al.
Age and Ageing|May 13, 2006
Women with wrist fractures are at increased risk for future fractures because of both skeletal and non-skeletal risk factorsBeatrice J Edwards, Craig B Langman, Kathy Martinez, et al.
International Urology and Nephrology|February 21, 2019
ALLN-177, oral enzyme therapy for hyperoxaluriaJames E Lingeman, Gyan Pareek, Linda Easter, et al.
Journal of Pediatric Orthopedics|November 25, 2015
Vitamin D Insufficiency and Fracture Risk in Urban ChildrenRachel M Thompson, Daniel M Dean, Sarah Goldberg, et al.
The Journal of Pediatrics|July 27, 2014
Fibroblast growth factor-23 in obese, normotensive adolescents is associated with adverse cardiac structureFarah N Ali, Bonita Falkner, Samuel S Gidding, et al.
Pageof 12